Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.14.5 extracted from

  • Green, B.D.; Irwin, N.; Duffy, N.A.; Gault, V.A.; Oharte, F.P.; Flatt, P.R.
    Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1 (2006), Eur. J. Pharmacol., 547, 192-199.
    View publication on PubMed

Application

Application Comment Organism
medicine metformin decreases the plasma DPP IV activity, limiting the inactivation of exogenously administered GLP-1 and improving glycaemic control Mus musculus

Inhibitors

Inhibitors Comment Organism Structure
metformin
-
Mus musculus

Organism

Organism UniProt Comment Textmining
Mus musculus
-
-
-

Source Tissue

Source Tissue Comment Organism Textmining
blood plasma
-
Mus musculus
-

Synonyms

Synonyms Comment Organism
DPP IV
-
Mus musculus

IC50 Value

IC50 Value IC50 Value Maximum Comment Organism Inhibitor Structure
0.029
-
ob/ob diabetic mice Mus musculus metformin
0.038
-
normal mice Mus musculus metformin